BACKGROUND: Among nondiabetic individuals, mild glucose decrements alter brain activity in regions linked to reward, motivation, and executive control. Whether these effects differ in type 1 diabetes mellitus (T1DM) patients with and without hypoglycemia awareness remains unclear. METHODS: Forty-two individuals (13 healthy control [HC] subjects, 16 T1DM individuals with hypoglycemia awareness [T1DM-Aware], and 13 T1DM individuals with hypoglycemia unawareness [T1DM-Unaware]) underwent blood oxygen level-dependent functional MRI brain imaging during a 2-step hyperinsulinemic euglycemic (90 mg/dl)-hypoglycemic (60 mg/dl) clamp for assessment of neural responses to mild hypoglycemia. RESULTS: Mild hypoglycemia in HC subjects altered activity in the caudate, insula, prefrontal cortex, and angular gyrus, whereas T1DM-Aware subjects showed no caudate and insula changes, but showed altered activation patterns in the prefrontal cortex and angular gyrus. Most strikingly, in direct contrast to HC and T1DM-Aware subjects, T1DM-Unaware subjects failed to show any hypoglycemia-induced changes in brain activity. These findings were also associated with blunted hormonal counterregulatory responses and hypoglycemia symptom scores during mild hypoglycemia. CONCLUSION: In T1DM, and in particular T1DM-Unaware patients, there is a progressive blunting of brain responses in cortico-striatal and fronto-parietal neurocircuits in response to mild-moderate hypoglycemia. These findings have implications for understanding why individuals with impaired hypoglycemia awareness fail to respond appropriately to falling blood glucose levels. FUNDING: This study was supported in part by NIH grants R01DK020495, P30 DK045735, K23DK109284, K08AA023545. The Yale Center for Clinical Investigation is supported by an NIH Clinical Translational Science Award (UL1 RR024139).
BACKGROUND: Among nondiabetic individuals, mild glucose decrements alter brain activity in regions linked to reward, motivation, and executive control. Whether these effects differ in type 1 diabetes mellitus (T1DM) patients with and without hypoglycemia awareness remains unclear. METHODS: Forty-two individuals (13 healthy control [HC] subjects, 16 T1DM individuals with hypoglycemia awareness [T1DM-Aware], and 13 T1DM individuals with hypoglycemia unawareness [T1DM-Unaware]) underwent blood oxygen level-dependent functional MRI brain imaging during a 2-step hyperinsulinemic euglycemic (90 mg/dl)-hypoglycemic (60 mg/dl) clamp for assessment of neural responses to mild hypoglycemia. RESULTS: Mild hypoglycemia in HC subjects altered activity in the caudate, insula, prefrontal cortex, and angular gyrus, whereas T1DM-Aware subjects showed no caudate and insula changes, but showed altered activation patterns in the prefrontal cortex and angular gyrus. Most strikingly, in direct contrast to HC and T1DM-Aware subjects, T1DM-Unaware subjects failed to show any hypoglycemia-induced changes in brain activity. These findings were also associated with blunted hormonal counterregulatory responses and hypoglycemia symptom scores during mild hypoglycemia. CONCLUSION: In T1DM, and in particular T1DM-Unaware patients, there is a progressive blunting of brain responses in cortico-striatal and fronto-parietal neurocircuits in response to mild-moderate hypoglycemia. These findings have implications for understanding why individuals with impaired hypoglycemia awareness fail to respond appropriately to falling blood glucose levels. FUNDING: This study was supported in part by NIH grants R01DK020495, P30 DK045735, K23DK109284, K08AA023545. The Yale Center for Clinical Investigation is supported by an NIH Clinical Translational Science Award (UL1 RR024139).
Authors: Barbara I Gulanski; Henk M De Feyter; Kathleen A Page; Renata Belfort-DeAguiar; Graeme F Mason; Douglas L Rothman; Robert S Sherwin Journal: J Clin Endocrinol Metab Date: 2013-06-24 Impact factor: 5.958
Authors: Evita C Wiegers; Kirsten M Becker; Hanne M Rooijackers; Federico C von Samson-Himmelstjerna; Cees J Tack; Arend Heerschap; Bastiaan E de Galan; Marinette van der Graaf Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Gail Musen; Donald C Simonson; Nicolas R Bolo; Amy Driscoll; Katie Weinger; Annaswamy Raji; Jean Théberge; Perry F Renshaw; Alan M Jacobson Journal: J Clin Endocrinol Metab Date: 2008-01-15 Impact factor: 5.958
Authors: Nicolas R Bolo; Gail Musen; Alan M Jacobson; Katie Weinger; Richard L McCartney; Veronica Flores; Perry F Renshaw; Donald C Simonson Journal: Diabetes Date: 2011-10-07 Impact factor: 9.461
Authors: Barbara Riegel; Maddalena De Maria; Claudio Barbaranelli; Maria Matarese; Davide Ausili; Anna Stromberg; Ercole Vellone; Tiny Jaarsma Journal: Front Public Health Date: 2022-05-17
Authors: Ruth McManus; Seva Ioussoufovitch; Elizabeth Froats; Keith St Lawrence; Stan Van Uum; Mamadou Diop Journal: Sci Rep Date: 2020-12-04 Impact factor: 4.379
Authors: Kristina E Almby; Martin H Lundqvist; Niclas Abrahamsson; Sofia Kvernby; Markus Fahlström; Maria J Pereira; Malin Gingnell; F Anders Karlsson; Giovanni Fanni; Magnus Sundbom; Urban Wiklund; Sven Haller; Mark Lubberink; Johan Wikström; Jan W Eriksson Journal: Diabetes Date: 2021-03-04 Impact factor: 9.461